Start for free
Start for free
Clough Capital Partners logo

Clough Capital Partners

North America, Massachusetts, United States, Boston

Description

Clough Capital Partners, L.P. is a Boston-based investment management firm

Investor Profile

Clough Capital Partners has made 11 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (36%)
  • Series B (36%)
  • Series E (18%)
  • Series D (9%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Therapeutics
  • Life Science
  • Medical
  • Medical Device
  • Health Diagnostics
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Clough Capital Partners frequently co-invest with?

Omega Funds
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 3
CaaS Capital Management
CaaS Capital Management
North America, New York, United States, New York
Co-Investments: 2
New Enterprise Associates
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 2
LG Technology Ventures
LG Technology Ventures
North America, California, United States, Santa Clara
Co-Investments: 2
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 3
SR One
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
Longitude Capital
Longitude Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Franklin Templeton
Franklin Templeton
North America, California, United States, San Mateo
Co-Investments: 2
Takeda Ventures
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 2
+ND Capital
+ND Capital
North America, California, United States, San Mateo
Co-Investments: 2

Which angels does Clough Capital Partners often collaborate with?

David Pyott
David Pyott
North America, California, United States, Orange
Shared Deals: 1
FB
Franklin Berger
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Clough Capital Partners?

Arcellx

Gaithersburg, Maryland, United States

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Series CApr 13, 2021
Amount Raised: $115,000,000
Amunix

South San Francisco, California, United States

Amunix is a biopharmaceutical company intended to discover, design, and develop novel biologics, protein, and peptide therapeutics.

BiotechnologyMedicalTherapeutics
Series BMar 4, 2021
Amount Raised: $117,000,000
Checkmate Pharmaceuticals

Cambridge, Massachusetts, United States

Checkmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.

BiotechnologyMedical DevicePharmaceuticalTherapeutics
Series CJun 10, 2020
Amount Raised: $85,000,000
Arcellx

Gaithersburg, Maryland, United States

Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.

BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Series BOct 3, 2019
Amount Raised: $85,000,000
Amphivena Therapeutics

South San Francisco, California, United States

Amphivena Therapeutics is a clinical-stage immuno-oncology company that develops a platform of dual-function biologics.

BiotechnologyHealth CareOncologyTherapeutics
Series CSep 24, 2019
Amount Raised: $62,000,000
ARMO BioSciences

Redwood City, California, United States

ARMO Biosciences is a biotechnology company that develops immune modulatory biologic therapeutics.

BiotechnologyHealth CareMedical Device
Series CAug 29, 2017
Amount Raised: $67,000,000
Apellis Pharmaceuticals

Waltham, Massachusetts, United States

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series EAug 10, 2017
Amount Raised: $60,000,000
Sienna Biopharmaceuticals

Westlake Village, California, United States

Clinical development and commercialization of innovative aesthetics and medical dermatology products based on scientific breakthroughs

BiotechnologyMedicalPharmaceutical
Series BApr 24, 2017
Amount Raised: $40,000,000
CRISPR Therapeutics

Cambridge, Massachusetts, United States

CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.

BiopharmaBiotechnologyGeneticsMedical
Series BJun 24, 2016
Amount Raised: $38,000,000
Elcelyx Therapeutics

San Diego, California, United States

Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.

BiotechnologyHealth CareHealth Diagnostics
Series EOct 1, 2015
Amount Raised: $40,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator